Antinociceptive properties of intrathecal dexmedetomidine in rats

Brock Fisher, Mark Zornow, Tony L. Yaksh, Bradley M. Peterson

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Dexmedetomidine is a highly selective α2-adrenoceptor agonist. In this study, the intrathecal administration of dexmedetomidine into the rat lumbar subarachnoid space produced dose-dependent, prolonged antinociception as measured by hot plate and tail flick testing. Intrathecal administration of 3 or 10 μg of dexmedetomidine increased hot plate and tail flick latencies to cutoff values within 15 min of injection. Animals receiving 1 μg of intrathecal dexmedetomidine did not show any significant antinociception when compared to saline controls. The intrathecal administration of the α2-adrenoceptor antagonist, idazoxan, ablated all measurable antinociception produced by the prior injection of 10 μg of dexmedetomidine.

Original languageEnglish (US)
Pages (from-to)221-225
Number of pages5
JournalEuropean Journal of Pharmacology
Volume192
Issue number2
DOIs
StatePublished - Jan 10 1991
Externally publishedYes

Fingerprint

Dexmedetomidine
Adrenergic Receptors
Tail
Idazoxan
Subarachnoid Space
Injections

Keywords

  • (Intrathecal)
  • Antinociception
  • Dexmedetomidine
  • α-Adrenoceptors

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Antinociceptive properties of intrathecal dexmedetomidine in rats. / Fisher, Brock; Zornow, Mark; Yaksh, Tony L.; Peterson, Bradley M.

In: European Journal of Pharmacology, Vol. 192, No. 2, 10.01.1991, p. 221-225.

Research output: Contribution to journalArticle

Fisher, Brock ; Zornow, Mark ; Yaksh, Tony L. ; Peterson, Bradley M. / Antinociceptive properties of intrathecal dexmedetomidine in rats. In: European Journal of Pharmacology. 1991 ; Vol. 192, No. 2. pp. 221-225.
@article{4aad6b37a2f94116ad30e20206777240,
title = "Antinociceptive properties of intrathecal dexmedetomidine in rats",
abstract = "Dexmedetomidine is a highly selective α2-adrenoceptor agonist. In this study, the intrathecal administration of dexmedetomidine into the rat lumbar subarachnoid space produced dose-dependent, prolonged antinociception as measured by hot plate and tail flick testing. Intrathecal administration of 3 or 10 μg of dexmedetomidine increased hot plate and tail flick latencies to cutoff values within 15 min of injection. Animals receiving 1 μg of intrathecal dexmedetomidine did not show any significant antinociception when compared to saline controls. The intrathecal administration of the α2-adrenoceptor antagonist, idazoxan, ablated all measurable antinociception produced by the prior injection of 10 μg of dexmedetomidine.",
keywords = "(Intrathecal), Antinociception, Dexmedetomidine, α-Adrenoceptors",
author = "Brock Fisher and Mark Zornow and Yaksh, {Tony L.} and Peterson, {Bradley M.}",
year = "1991",
month = "1",
day = "10",
doi = "10.1016/0014-2999(91)90046-S",
language = "English (US)",
volume = "192",
pages = "221--225",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Antinociceptive properties of intrathecal dexmedetomidine in rats

AU - Fisher, Brock

AU - Zornow, Mark

AU - Yaksh, Tony L.

AU - Peterson, Bradley M.

PY - 1991/1/10

Y1 - 1991/1/10

N2 - Dexmedetomidine is a highly selective α2-adrenoceptor agonist. In this study, the intrathecal administration of dexmedetomidine into the rat lumbar subarachnoid space produced dose-dependent, prolonged antinociception as measured by hot plate and tail flick testing. Intrathecal administration of 3 or 10 μg of dexmedetomidine increased hot plate and tail flick latencies to cutoff values within 15 min of injection. Animals receiving 1 μg of intrathecal dexmedetomidine did not show any significant antinociception when compared to saline controls. The intrathecal administration of the α2-adrenoceptor antagonist, idazoxan, ablated all measurable antinociception produced by the prior injection of 10 μg of dexmedetomidine.

AB - Dexmedetomidine is a highly selective α2-adrenoceptor agonist. In this study, the intrathecal administration of dexmedetomidine into the rat lumbar subarachnoid space produced dose-dependent, prolonged antinociception as measured by hot plate and tail flick testing. Intrathecal administration of 3 or 10 μg of dexmedetomidine increased hot plate and tail flick latencies to cutoff values within 15 min of injection. Animals receiving 1 μg of intrathecal dexmedetomidine did not show any significant antinociception when compared to saline controls. The intrathecal administration of the α2-adrenoceptor antagonist, idazoxan, ablated all measurable antinociception produced by the prior injection of 10 μg of dexmedetomidine.

KW - (Intrathecal)

KW - Antinociception

KW - Dexmedetomidine

KW - α-Adrenoceptors

UR - http://www.scopus.com/inward/record.url?scp=0026059514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026059514&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(91)90046-S

DO - 10.1016/0014-2999(91)90046-S

M3 - Article

VL - 192

SP - 221

EP - 225

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2

ER -